FDA Drug Application (200629) for NAPROXEN SODIUM by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number200629
Product Number001
FormTABLET;ORAL
DosageEQ 250MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROXEN SODIUM
Active IngredientNAPROXEN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN SODIUM12


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD